Enrich Biosystems
PrivateLast Round
VC Round
Jun 15, 2022
Total Funding Raised
$320,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Enrich Biosystems operates in Healthcare & Life Sciences and is based in Branford, Connecticut. Its latest recorded funding round was a VC Round in June 2022.
Enrich Biosystems is a biotechnology company that develops a microfluidics-free cell analysis and retrieval platform for therapeutic development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enrich Biosystems Comparables
Compare Enrich Biosystems with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cell Microsystems | 86% | |
| CellChorus | 82% | |
| Partillion Bioscience Corporation | 80% |
For institutional investors. Book with your work email.
Enrich Biosystems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 15, 2022 | ||||
| Accelerator | Jul 29, 2021 | ||||
| Seed | Jul 15, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Enrich Biosystems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Seed |
| Elm Street Ventures | VC Round |
| BioTools Innovator | Accelerator |
| Boston Harbor Angels | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 2358% MoM, reaching 1.4K.
- May 18, 2026
Monthly visitors increased 290% MoM, from 178 to 695.
For institutional investors. Book with your work email.
Enrich Biosystems Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Enrich Biosystems's valuation, stock price, and market status.
Is Enrich Biosystems a public or private company?
Enrich Biosystems is a private company.
What is the current stock price of Enrich Biosystems?
Enrich Biosystems is a private company, so its shares have no public market price. Caplight tracks Enrich Biosystems's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Enrich Biosystems worth (valuation)?
Valuation information for Enrich Biosystems is not publicly available.
Can I buy Enrich Biosystems stock?
Enrich Biosystems shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Enrich Biosystems's last funding round?
Enrich Biosystems's most recent funding round was VC Round on June 15, 2022.
Who are the main investors in Enrich Biosystems?
Key investors in Enrich Biosystems include Connecticut Innovations.
Will Enrich Biosystems IPO soon?
No public IPO plans have been announced for Enrich Biosystems.
How can I track Enrich Biosystems secondary market activity?
Caplight tracks bids, offers, and trades in Enrich Biosystems's shares on secondary markets.